Basketball players, baseball pitchers, and athletes warm up before they perform, and now researchers in the US are investigating whether surgeons should do the same to ensure they are better prepared for when they have to perform. Dr Tom Lendvay, assistant professor in the Department of Urology at the University of Washington in Seattle thinks there could be something in this idea, and to this end the US Army Medical Research and Materiel Command has awarded him some funds to study the effect of pre-operative warm-up on virtual reality surgical task proficiency. Maj Timothy Brand, a surgeon based at Madigan Army Medical Center in Tacoma, Washington, is collaborating with Lendvay on the study.
Validation In A Multiple Urology Practice Cohort Of The Prostate Cancer Prevention Trial Calculator For Predicting Prostate Cancer Detection
UroToday.com - One of many outcomes measures from the Prostate Cancer Prevention Trial was the development of a prostate cancer (CaP) risk calculator. However, the cohort of men in PCPT was different than men routinely referred for prostate biopsy. In the December 2009 issue of the Journal of Urology, Dr. Stephen Eyre and multicenter collaborators validate the PCPT risk calculator using men from 5 urology practices participating in the Early Detection Research Network (EDRN). The assessment of the PCPT risk calculator was done by calculating the area under the receiver operating curve (AUC), sensitivity, specificity and by calibration comparing PCPT calculator predicted vs.
The Influence Of Psychiatric Comorbidities And Sexual Trauma On Lower Urinary Tract Symptoms In Female Veterans
UroToday.com - Psychosocial conditions including depression, anxiety disorders and sexual trauma have been identified as risk factors for overactive bladder and incontinence. Could psychosocial factors and emotional influences play a role in the production or perception of lower urinary tract symptoms? Davilla has reported that 72% of sexual abuse survivors reported incontinence vs. 22% of controls. (J Urol 2003:170:476). In a new publication, Adam Klausner and colleagues from Richmond, VA characterized the type, severity, and quality of life impact of lower urinary tract symptoms (LUTS) in patients with psychiatric comorbidities and/or sexual trauma.
On Tuesday government ministers announced that NHS Patients will now have their rights enshrined in the NHS Constitution. This means that all NHS organizations are legally obliged to provide drugs that have been approved by the National Institute for Health and Clinical Excellence and treat all patients with dignity and respect in their choice of location. The James Whale Fund for Kidney cancer believes the constitution is a step in the right direction and is particularly interested in the clause that ensures all patients will get the drugs they need. Since Kidney Cancer is a type of cancer which cannot be treated with chemotherapy or radiation.
Researchers at Moores Cancer Center at the University of California, San Diego and colleagues have found that prostate cancer treatments varied significantly between county hospitals and private providers. Patients treated in county hospitals are more likely to undergo surgery while patients treated in private facilities tend to receive radiation or hormone therapy. These findings were published online by the journal CANCER on January 25. "The study examined the factors that drive treatment choices for patients with prostate cancer" said J. Kellogg Parsons, MD, MHS, principal investigator and urologic oncologist at Moores UCSD Cancer Center.
Investigators have identified a new disease mechanism and therapeutic approach for a type of advanced kidney disease that is a common cause of complications in patients with lupus. The study was led by investigators at Hospital for Special Surgery and appears in the January 25 online Early Edition of the Proceedings of the National Academy of Sciences. "The standard treatment for lupus kidney disease is to block inflammation, " said Lionel Ivashkiv, M.D., associate chief scientific officer at Hospital for Special Surgery in New York City. "This study suggests you might want to target the macrophages, a specific type of white blood cell involved in the disease.